Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Association of Novel Single Nucleotide Polymorphisms of Genes Involved in Cell Functions with Male Infertility: A Study of Male Cases in Northwest Iran

Authors
1 Department of Genetics, Faculty of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran
2 Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran
3 Biology Department, Faculty of Bio Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran
4 Department of Genetics, Faculty of Biological Sciences, Tabriz Branch, Islamic Azad University, Tabriz, Iran
Abstract
Background: Infertility is a global health problem caused by various environmental and genetic factors. Male infertility accounts for 40–50% of all cases of infertility and approximately half of them are grouped as idiopathic with no definitive causes. Previous studies have suggested an association between some SNPs and infertility in men. In this study, an attempt was made to investigate the association of 7 different SNPs of 4 genes involved in common cell functions with male infertility. Methods: MTHFR rs1801131 (T>G), MTHFR rs2274976 (G>A), FASLG rs80358238 (A>G), FASLG rs12079514 (A>C), GSTM1 rs1192077068 (G>A), BRCA2 rs4987117(C>T), and BRCA2 rs11571833 (A>T) were genotyped in 120 infertile men with idiopathic azoospermia or severe oligospermia and 120 proven fertile controls using ARMS-PCR methods. Next, 30% of SNPs were regenotyped to confirm the results. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using SPSS statistical software to evaluate the strength of association. The p˂0.05 were considered statistically significant. Results: Statistical analysis revealed significant association between MTHFR rs2274976 AA variant (OR: 10.00, CI: 3.203-31.225), FASLG rs12079514 AC variant (OR: 0.412, CI: 0.212-0.800), and BRCA2 rs11571833 TT variant OR: 6.233, CI: 3.211-12.101) with male infertility, but there was no significant difference between case and control groups in MTHFR rs1801131 (p= 0.111), GSTM1 rs1192077068 (p=0.272), BRCA2 rs4987117 (p=0.221), and FASLG rs80358238 (p=0.161). Conclusion: Our findings suggested that some novel polymorphisms including MTHFR rs2274976, FASLG rs12079514, and BRCA2 rs11571833 might be the possible predisposing risk factors for male infertility in cases with idiopathic azoospermia.
Keywords

  1. Tirumala Vani G, Mukesh N, Siva Prasad B, Rama Devi P, Hema Prasad M, Usha Rani P, et al. Role of glutathione S‐transferase Mu‐1 (GSTM1) polymorphism in oligospermic infertile males. Andrologia. 2010;42(4):213-7.
  2. Babu SR, Swarna M, Padmavathi P, Reddy P. PCR analysis of Yq microdeletions in infertile males, a study from South India. Asian J Androl. 2002;4(4):265-8.
  3. Hamada AJ, Esteves SC, Agarwal A. A comprehensive review of genetics and genetic testing in azoospermia. Clinics (Sao Paulo). 2013;68(Suppl 1):39-60.
  4. Wu W, Lu J, Tang Q, Zhang S, Yuan B, Li J, et al. GSTM1 and GSTT1 null polymorphisms and male infertility risk: an updated meta-analysis encompassing 6934 subjects. Sci Rep. 2013;3:2258.
  5. O'Brien KLF, Varghese AC, Agarwal A. The genetic causes of male factor infertility: a review. Fertil Steril. 2010;93(1):1-12.
  6. Ferlin A, Raicu F, Gatta V, Zuccarello D, Palka G, Foresta C. Male infertility: role of genetic background. Reprod Biomed Online. 2007;14(6):734-45.
  7. Đorđević V, Nikolić A, Ljujić M, Nestorović A, Ristanović M, Tulić C, et al. Combined effect of GSTM1 gene deletion, GSTT1 gene deletion and MTHFR C677T mutation in male infertility. Arch Biol Sci Belgrade. 2010;62(3):525-30.
  8. Krausz C, Escamilla AR, Chianese C. Genetics of male infertility: from research to clinic. Reproduction. 2015;150(5):R159-74.
  9. Hotaling JM. Genetics of male infertility. Urol Clin North Am. 2014;41(1):1-17.
  10. Aston KI, Conrad DF. A review of genome-wide approaches to study the genetic basis for spermatogenic defects. Methods Mol Biol. 2013;927:397-410.
  11. Agarwal A, Prabakaran S, Allamaneni S. What an andrologist/urologist should know about free radicals and why. Urology. 2006;67(1):2-8.
  12. Tremellen K. Oxidative stress and male infertility--a clinical perspective. Hum Reprod Update. 2008;14(3):243-58.
  13. Iwasaki A, Gagnon C. Formation of reactive oxygen species in spermatozoa of infertile patients. Fertil Steril. 1992;57(2):409-16.
  14. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44-84.
  15. Safarinejad MR, Dadkhah F, Asgari MA, Hosseini SY, Kolahi AA, Iran-Pour E. Glutathione S-transferase polymorphisms (GSTM1, GSTT1, GSTP1) and male factor infertility risk: a pooled analysis of studies. Urol J. 2012;9(3):541-8.
  16. Mirzaei B, Rahmani-Nia F, Salehi Z, Rahimi R, Faraji Saravani M, Ahmadi R, et al. Effects of GSTM1 gene polymorphism on oxidative DNA damage and lipid peroxidation following exhaustive exercise in young wrestlers. Med Sport. 2012;67:437-48.
  17. Park JH, Lee HC, Jeong YM, Chung TG, Kim HJ, Kim NK, et al. MTHFR C677T polymorphism associates with unexplained infertile male factors. J Assist Reprod Genet. 2005;22(9-10):361-8.
  18. Bailey LB, Gregory 3rd JF. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr. 1999;129(5):919-22.
  19. Wei B, Xu Z, Ruan J, Zhu M, Jin K, Zhou D, et al. MTHFR 677C> T and 1298A> C polymorphisms and male infertility risk: a meta-analysis. Mol Biol Rep. 2012;39(2):1997-2002.
  20. Trabetti E. Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk. J Appl Genet. 2008;49(3):267-82.
  21. Tüttelmann F, Rajpert-De Meyts E, Nieschlag E, Simoni M. Gene polymorphisms and male infertility--a meta-analysis and literature review. Reprod Biomed Online. 2007;15(6):643-58.
  22. Jaiswal D, Trivedi S, Agrawal NK, Singh K. Association of polymorphism in cell death pathway gene FASLG with human male infertility. Asian Pacific J Reprod. 2015;4(2):112-5.
  23. Shukla KK, Mahdi AA, Rajender S. Apoptosis, spermatogenesis and male infertility. Front Biosci (Elite Ed). 2012;4:746-54.
  24. Martincic DS, Klun IV, Zorn B, Vrtovec HM. Germ cell apoptosis in the human testis. Pflugers Arch. 2001;442(6 Suppl 1):R159-60.
  25. Lee CH, Cho YH. Aspects of mammalian spermatogenesis: electrophoretical analysis of protamines in mammalian species. Mol Cells. 1999;9(5):556-9.
  26. Balkan M, Atar M, Erdal ME, Rustemoğlu A, Yildiz I, Gunesacar R, et al. Possible association of FAS and FASLG polymorphisms with the risk of idiopathic azoospermia in southeast Turkey. Genet Test Mol Biomarkers. 2014;18(6):383-8.
  27. Del Giudice PT, Lima SB, Cenedeze MA, Pacheco-Silva Á, Bertolla RP, Cedenho AP. Expression of the Fas-ligand gene in ejaculated sperm from adolescents with and without varicocele. J Assist Reprod Genet. 2010;27(2-3):103-9.
  28. Ji G, Gu A, Hu F, Wang S, Liang J, Xia Y, et al. Polymorphisms in cell death pathway genes are associated with altered sperm apoptosis and poor semen quality. Hum Reprod. 2009;24(10):2439-46.
  29. Tavtigian S, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet. 1996;12(3):333-7.
  30. Zhoucun A, Zhang S, Yang Y, Ma Y, Zhang W, Lin L. The common variant N372H in BRCA2 gene may be associated with idiopathic male infertility with azoospermia or severe oligozoospermia. Eur J Obstet Gynecol Reprod Biol. 2006;124(1):61-4.
  31. Zabludoff SD, Wright WW, Harshman K, Wold BJ. BRCA1 mRNA is expressed highly during meiosis and spermiogenesis but not during mitosis of male germ cells. Oncogene. 1996;13(3):649-53.
  32. Chen J, Silver DP, Walpita D, Cantor SB, Gazdar AF, Tomlinson G, et al. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol Cell. 1998;2(3):317-28.
  33. Lewis CM. Genetic association studies: design, analysis and interpretation. Brief Bioinform. 2002;3(2):146-53.
  34. Dohle GR, Halley DJ, Van Hemel JO, Van Den Ouwel AM, Pieters MH, Weber R, et al. Genetic risk factors in infertile men with severe oligozoospermia and azoospermia. Hum Reprod. 2002;17(1):13-6.
  35. Krausz C, Giachini C. Genetic risk factors in male infertility. Arch Androl. 2007;53(3):125-33.
  36. Holliday R. The biological significance of meiosis. Symp Soc Exp Biol. 1984;38:381-94.
  37. Aitken RJ, Krausz C. Oxidative stress, DNA damage and the Y chromosome. Reproduction. 2001;122(4):497-506.
  38. Bufalino A, Ribeiro Paranaíba LM, Nascimento de Aquino S, Martelli‐Júnior H, Oliveira Swerts MS, Coletta RD. Maternal polymorphisms in folic acid metabolic genes are associated with nonsyndromic cleft lip and/or palate in the Brazilian population. Birth Defects Res A Clin Mol Teratol. 2010;88(11):980-6.
  39. De Aquino SN, Hoshi R, Bagordakis E, Pucciarelli MGR, Messetti AC, Moreira H, et al. MTHFR rs2274976 polymorphism is a risk marker for nonsyndromic cleft lip with or without cleft palate in the Brazilian population. Birth Defects Res A Clin Mol Terat. 2014;100(1):30-5.
  40. Zhou BS, Bu GY, Li M, Chang BG, Zhou YP. Tagging SNPs in the MTHFR gene and risk of ischemic stroke in a Chinese population. Int J Mol Sci. 2014;15(5):8931-40.
  41. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev. 2001;10(12):1239-48.
  42. Rajender S, Rahul P, Mahdi AA. Mitochondria, spermatogenesis and male infertility. Mitochondrion. 2010;10(5):419-28.
  43. Aitken RJ, Koppers AJ. Apoptosis and DNA damage in human spermatozoa. Asian J Androl. 2011;13(1):36-42.
  44. Print CG, Loveland KL. Germ cell suicide: new insights into apoptosis during spermatogenesis. Bioessays. 2000;22(5):423-30.
  45. Zhang Z, Wang LE, Sturgis EM, El-Naggar AK, Hong WK, Amos CI, et al. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2006;12(18):5596-602.
  46. Sun T, Miao X, Zhang X, Tan W, Xiong P, Lin D. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst. 2004;96(13):1030-6.
  47. Asgari R, Mansouri K, Bakhtiari M, Bidmeshkipour A, Yari K, Shaveisi-Zadeh F, et al. Association of FAS-670A/G and FASL-844C/T polymorphisms with idiopathic azoospermia in western Iran. Eur J Obstet Gynecol Reprod Biol. 2017;218:55-9.
  48. Sharan SK, Pyle A, Coppola V, Babus J, Swaminathan S, Benedict J, et al. BRCA2 deficiency in mice leads to meiotic impairment and infertility. Development. 2004;131(1):131-42.
  49. Kwiatkowski F, Arbre M, Bidet Y, Laquet C, Uhrhammer N, Bignon YJ. BRCA mutations increase fertility in families at hereditary breast/ovarian cancer risk. PLoS One. 2015;10(6):e0127363.
  50. Blackshear PE, Goldsworthy SM, Foley JF, McAllister KA, Bennett LM, Collins NK, et al. Brca1 and Brca2 expression patterns in mitotic and meiotic cells of mice. Oncogene. 1998;16(1):61-8.
  51. Ge Y, Wang Y, Shao W, Jin J, Du M, Ma G, et al. Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers. Sci Rep. 2016;6:33542.
  52. Krupa R, Sliwinski T, Morawiec Z, Pawlowska E, Zadrozny M, Blasiak J. Association between polymorphisms of the BRCA2 gene and clinical parameters in breast cancer. Exp Oncol. 2009;31(4):250-1.